BMJ Open · 2019 · 12 citations · 20 references
MedicineHealth Services AdministrationHealth Services ResearchHealthcare Quality ImprovementOutcomes ResearchAcute Stroke ManagementClinical TrialsStrokeThrombolytic TherapyAcute Ischemic Stroke ManagementDoor-to-needle Time ReductionHealth Behavior ChangeMonitoring Of Thrombolytic TherapyPost Hoc AnalysisPrimary Outcome AnalysisStroke Unit Nursing
OBJECTIVE: The current study aimed to evaluate the effects of a multi-component in-hospital intervention on the door-to-needle time for intravenous thrombolysis in acute ischaemic stroke. DESIGN: This study was a post hoc analysis of door-to-needle time data from a cluster-randomised controlled trial testing an intervention to boost intravenous thrombolysis implementation. SETTING: The study was conducted among 20 hospitals from three Australian states. PARTICIPANT: Eligible hospitals had a Stroke Care Unit or staffing equivalent to a stroke physician and a nurse, and were in the early stages of implementing thrombolysis. INTERVENTION: The intervention was multifaceted and developed using the behaviour change wheel and informed by breakthrough collaborative methodology using components of the health behaviour change wheel. PRIMARY AND SECONDARY OUTCOME MEASURES: The primary outcome for this analysis was door-to-needle time for thrombolysis and secondary outcome was the proportion of patients received thrombolysis within 60 min of hospital arrival. RESULTS: The intervention versus control difference in the door-to-needle times was non-significant overall nor significant by hospital classification. To provide additional context for the findings, we also evaluated the results within intervention and control hospitals. During the active-intervention period, the intervention hospitals showed a significant decrease in the door-to-needle time of 9.25 min (95% CI: -16.93 to 1.57), but during the post-intervention period, the result was not significant. During the active intervention period, control hospitals also showed a significant decrease in the door-to-needle time of 5.26 min (95% CI: -8.37 to -2.14) and during the post-intervention period, this trend continued with a decrease of 12.13 min (95% CI: -17.44 to 6.81). CONCLUSION: Across these primary stroke care centres in Australia, a secular trend towards shorter door-to-needle times across both intervention and control hospitals was evident, however the TIPS (Thrombolysis ImPlementation in Stroke) intervention showed no overall effect on door-to-needle times in the randomised comparison. TRIAL REGISTRATION NUMBER: Trial Registration-URL: http://www.anzctr.org.au/ Unique Identifier: ACTRN 12613000939796.
20
Timeliness of Tissue-Type Plasminogen Activator Therapy in Acute Ischemic Stroke
Gregg C. Fonarow, Eric E. Smith, Jeffrey L. Saver et al. · Circulation · 2011 · 579 citations
Reducing in-hospital delay to 20 minutes in stroke thrombolysis
Atte Meretoja, Daniel Strbian, Satu Mustanoja et al. · Neurology · 2012 · 557 citations